Loading clinical trials...
Loading clinical trials...
Research; It is a planned, non-invasive, controlled study in obese female volunteers and non-obese female volunteers. The population of the study consists of voluntarily non-obese women and obese women. Sarcopenia assets of individuals will be measured with the sarc-f questionnaire, and then muscle strength, muscle mass and physical performance tests will be measured. Then, rectus femoris muscle thickness will be measured with USG, and then walking and balance will be measured with ZEBRIS.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
Yes
Kütahya Health Sciences University
Kütahya, Centre, Turkey (Türkiye)
Start Date
October 15, 2022
Primary Completion Date
March 15, 2023
Completion Date
June 15, 2023
Last Updated
December 6, 2022
1
ESTIMATED participants
Ultrasonografi, Sarcopenia measurement, Zebris
DIAGNOSTIC_TEST
Lead Sponsor
Kutahya Health Sciences University
NCT07472881
NCT01143454
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions